Isto Biologics News and Activities

Isto Biologics is owned by Thompson Street Capital Partners.

Thompson Street Capital Partners has 4 subsidiaries including Bubbakoo's Burritos, Isto Biologics and Sabai.

They are in:

• Biotechnology40%
• Financial Services20%
• Other40%

View the org chart displaying its 19 main executives

Most searched biographies at Isto Biologics

• Don Brown, Chief Executive Officer
• Lindsay Murphy, Vice President of Sales
• Bryan Choi, Vice President, Research & Development

Create your alert
to follow the executive moves at Isto Biologics.

Thompson Street Capital Partners has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Ona Therapeutics has just announced a $87 Million fundraising (posted on June 5 2026).
• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by Isto Biologics

• What's New at Isto
• Isto Biologics
• Isto Biologics
• Isto Biologics

Social media about Isto Biologics

• Isto Biologics on Wikipedia, Google News & Yahoo Finance
• Isto Biologics on LinkedIn, X (Twitter) & YouTube